![Carl Kraus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carl Kraus
Directeur Technique/Scientifique/R&D chez AQUESTIVE THERAPEUTICS, INC.
Fortune : 756 000 $ au 31/05/2024
Postes actifs de Carl Kraus
Sociétés | Poste | Début | Fin |
---|---|---|---|
AQUESTIVE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 26/06/2023 | - |
i3 Research, Inc.
![]() i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Carl Kraus
Anciens postes connus de Carl Kraus
Sociétés | Poste | Début | Fin |
---|---|---|---|
ACERAGEN, INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 | 30/04/2023 |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Directeur Général | 01/01/2017 | 31/10/2021 |
Président | - | 31/10/2021 | |
Fondateur | 01/01/2015 | 31/10/2021 | |
President | - | 31/10/2021 | |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Directeur Technique/Scientifique/R&D | 28/09/2022 | - |
Resilience Government Services, Inc.
![]() Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Directeur Technique/Scientifique/R&D | 01/01/2007 | - |
Formation de Carl Kraus
Washington University School of Medicine | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ACERAGEN, INC. | Health Technology |
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
i3 Research, Inc.
![]() i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Commercial Services |
Resilience Government Services, Inc.
![]() Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Health Technology |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Health Technology |
Idera Pharmaceuticals, Inc.
![]() Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
- Bourse
- Insiders
- Carl Kraus
- Expérience